Roundhill Investments Reaches $10 Billion AUM Milestone
Year-to-date inflows have surpassed
Roundhill's year-to-date inflows have now totaled over
Key contributors to Roundhill's momentum include the Roundhill Magnificent Seven ETF (MAGS), the Generative AI & Technology ETF (CHAT), and the firm's rapidly expanding WeeklyPay™ ETF suite, which together highlight Roundhill's focus on both innovation and investor demand for differentiated income and growth strategies.
"Crossing
"We founded Roundhill eight years ago with a vision to disrupt the ETF industry by doing things differently, from how we innovate on products to how we reach investors," said
1Source: Bloomberg, as of
About Roundhill Investments
Founded in 2018, Roundhill Investments is an SEC-registered investment advisor focused on innovative exchange-traded funds. Roundhill's suite of ETFs aims to offer distinct and differentiated exposures across thematic equity, options income, and trading vehicles. Roundhill offers a depth of ETF knowledge and experience, as the team has collectively launched more than 100+ ETFs including several first-to-market products. For more information, please visit www.roundhillinvestments.com.
Carefully consider the investment objectives, risks, charges and expenses of Roundhill ETFs before investing. This and other information about each fund is contained in the Prospectus and Summary Prospectus. Please read the prospectus and summary prospectus carefully before investing as it explains the risks associated with investing in the ETFs. Each Fund prospectus can be found on the individual Fund page under https://www.roundhillinvestments.com/etf/.
All investing involves risk, including the risk of loss of principal. There is no guarantee an investment strategy will be successful.
Roundhill's funds are distributed by Foreside Fund Services, LLC.
View original content to download multimedia:https://www.prnewswire.com/news-releases/roundhill-investments-reaches-10-billion-aum-milestone-302607208.html
SOURCE Roundhill Investments
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Atossa Therapeutics closes $4.5 million registered direct offering
- Park Ha Biological partners with Star Plus Legend unit on AI skincare system
- FDA approves Merck's KEYTRUDA and WELIREG combination for kidney cancer
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share